A Conversation with Escape Bio

No team? No time? No problem! Mari Maurer, Vice President, Clinical Operations at ESCAPE Bio describes the challenges ESCAPE Bio faced in rapidly developing budgets for their clinical trials... And how they conquered these challenges. Learn:

1. Why accurate forecasting of clinical budgets is more important now than ever before.
2. How accurate forecasting can help public and private companies conserve cash in this volatile economic environment.
3. How technology provides accurate, detailed budget forecasts to increase transparency with partners.

Our speakers:

Brian Kelly, Sr. VP of Business Development, Strategikon

Brian has more than 20 years of experience supporting clinical research via specialized service providers, including SaaS, and scientific services. Brian managed global sales and business development for Judi by AG Mednet, a specialized clinical trial collaboration platform, and worked with Synarc, a leading imaging core laboratory. Prior to his career in sales, Brian spent several years in procurement and vendor management, as well as leading project teams in support of pivotal global programs in multiple therapeutic areas.

Mari Maurer, VP, Clinical Operations, ESCAPE Bio Ms. Maurer is an accomplished pharmaceutical and biotechnology professional with proven ability to successfully build and integrate high-performance teams. She has effectively managed small and large clinical operations, initiated innovation to clinical trial execution, and directed cross-functional teams. Ms. Maurer has expertise in strategic and operations planning, work process and infrastructure development, regulatory inspection readiness, patient recruitment and retention, and clinical trial budget forecasting and management. She applies her capabilities across multiple therapeutic areas with a focus in rare and ultra-rare disease indications.

ESCAPE Bio is a precision for medicine company developing targeted therapies for genetic neurodegenerative diseases.